• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿替洛尔前体脂质体经皮给药系统的研制及体外渗透研究

Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.

作者信息

Ramkanth Sundarapandian, Chetty Challa Madhusudhana, Sudhakar Yajamans

机构信息

Annamacharya College of Pharmacy, Rajampet, Andhra Pradesh, India.

Government Polytechnic for Women, Kadapa, Andhra Pradesh, India.

出版信息

Pak J Pharm Sci. 2014 Jan;27(1):115-20.

PMID:24374439
Abstract

Proniosomes refer to a flexible vesicular carrier with the potential for drug administration through the transdermal route. A proniosome gel type transdermal delivery system of Atenolol was prepared and extensively studied both in vitro drug release and ex vivo permeation studies. The prepared formulations were evaluated for vesicle size, entrapment efficiency, in vitro drug loading, and drug release studies. The release of drug had shown considerable improvement in controlled manner from the prepared gel formulation. It was observed that Span 40 & 60 (A 8) based formulations shows vesicles of minimum size and higher entrapment efficiency compared to the other formulations. Proniosomal transdermal therapeutic system (A 8) was found to be the optimized formulation as it possess good drug release and shows permeation in a steady-state manner over a desired period of time. Also the drug diffusion across snake sheded skin, guinea pig abdomen skin, albino rat, porcine ear correlates better with in vitro drug release studies. The formulation was found to be stable when stored at room temperature and at refrigeration temperature (4 ± 2°C) for 90 days.

摘要

前体脂质体是一种具有通过透皮途径给药潜力的柔性囊泡载体。制备了阿替洛尔的前体脂质体凝胶型透皮给药系统,并对其体外药物释放和离体渗透进行了广泛研究。对制备的制剂进行了囊泡大小、包封率、体外载药量和药物释放研究。药物从制备的凝胶制剂中以可控方式释放有了显著改善。观察到,与其他制剂相比,基于司盘40和60(A8)的制剂显示出最小尺寸的囊泡和更高的包封率。前体脂质体透皮治疗系统(A8)被认为是优化制剂,因为它具有良好的药物释放性能,并在所需时间段内以稳态方式显示渗透。此外,药物在蛇蜕皮肤、豚鼠腹部皮肤、白化大鼠、猪耳上的扩散与体外药物释放研究相关性更好。该制剂在室温及冷藏温度(4±2°C)下储存90天时被发现是稳定的。

相似文献

1
Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.阿替洛尔前体脂质体经皮给药系统的研制及体外渗透研究
Pak J Pharm Sci. 2014 Jan;27(1):115-20.
2
Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.氯沙坦钾前体脂质体透皮治疗系统:研发与药代动力学评价
J Drug Target. 2009 Jul;17(6):442-9. doi: 10.1080/10611860902963039.
3
Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.纳米前体脂质体增强甲芬那酸的透皮递送
J Liposome Res. 2014 Dec;24(4):280-9. doi: 10.3109/08982104.2014.911313. Epub 2014 Apr 29.
4
Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.局部脂质体中的他莫昔芬:研发、表征及体外评价
J Pharm Pharm Sci. 2004 Jul 16;7(2):252-9.
5
Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.新型非离子表面活性剂 proniosomes 经皮传递拉西地平:采用 2(3) 因子设计优化和兔体内评价。
Drug Deliv. 2016 Jun;23(5):1608-22. doi: 10.3109/10717544.2015.1132797. Epub 2016 Jan 13.
6
Formulation and evaluation of proniosomes containing lornoxicam.载有氯诺昔康的前体药物的配方与评估。
Drug Deliv Transl Res. 2016 Oct;6(5):511-8. doi: 10.1007/s13346-016-0296-9.
7
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.通过乙醇脂质体进行抗银屑病药物的真皮和透皮给药。
J Control Release. 2007 Nov 6;123(2):148-54. doi: 10.1016/j.jconrel.2007.08.005. Epub 2007 Aug 16.
8
Proniosomes as a drug carrier for transdermal delivery of ketorolac.作为酮咯酸透皮给药载体的前体脂质体
Eur J Pharm Biopharm. 2005 Apr;59(3):485-90. doi: 10.1016/j.ejpb.2004.09.006.
9
A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation.一种新型硝苯地平的囊泡经皮给药——制剂、表征及体外/体内评价
Drug Deliv. 2016;23(2):619-30. doi: 10.3109/10717544.2014.931484. Epub 2014 Jul 9.
10
Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.评价前体脂质体作为优化吡罗昔康经皮传递的替代策略。
J Microencapsul. 2009 May;26(3):272-8. doi: 10.1080/02652040802305618. Epub 2008 Oct 20.

引用本文的文献

1
Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study.原前体凝胶衍生的尼莫司汀:一种持续改善酒石酸溴莫尼定眼部递药的方法;制剂、体外特征及体内药效学研究。
Drug Deliv. 2019 Dec;26(1):509-521. doi: 10.1080/10717544.2019.1609622.